EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,950.00
+127.00 (6.97%)
At close: Aug 11, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 84.3 billion as of August 11, 2026. Its market cap has decreased by -5.49% in one year.
Market Cap
84.30B
Enterprise Value
42.17B
Revenue
4.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,950.00
ChartMarket Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 84.30B, a decrease of -35.65%. That is a compound annual growth rate of -4.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 84.30B | 12.13% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 86.00B |
| SunBio,Inc. | 79.38B |
| CTCBIO | 73.28B |
| BIO-FD&C | 71.57B |
| QuadMedicine | 70.61B |
| IMGT Co.,Ltd. | 68.17B |
| PanGen Biotech | 67.44B |
| AriBioLab | 65.13B |